Modeling Hypertrophic Cardiomyopathy with Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2022 Jun 6

PMID 35659761

Authors

Jiangtao Li

Xin Feng

Xiang Wei

Affiliations

Soon will be listed here.

Abstract

One of the obstacles in studying the pathogenesis of hypertrophic cardiomyopathy (HCM) is the poor availability of myocardial tissue samples at the early stages of disease development. This has been addressed by the advent of induced pluripotent stem cells (iPSCs), which allow us to differentiate patient-derived iPSCs into cardiomyocytes (iPSC-CMs) in vitro. In this review, we summarize different approaches to establishing iPSC models and the application of genome editing techniques in iPSC. Because iPSC-CMs cultured at the present stage are immature in structure and function, researchers have attempted several methods to mature iPSC-CMs, such as prolonged culture duration, and mechanical and electrical stimulation. Currently, many researchers have established iPSC-CM models of HCM and employed diverse methods for performing measurements of cellular morphology, contractility, electrophysiological property, calcium handling, mitochondrial function, and metabolism. Here, we review published results in humans to date within the growing field of iPSC-CM models of HCM. Although there is no unified consensus, preliminary results suggest that this approach to modeling disease would provide important insights into our understanding of HCM pathogenesis and facilitate drug development and safety testing.

Citing Articles

Advancements in techniques for human iPSC-derived cardiomyocytes maturation: mechanical and electrical stimulation approaches.

Lu Y, Liu Y, Yan Y, Fooladi S, Qyang Y Biophys Rev. 2025; 17(1):169-183.

PMID: 40060015 PMC: 11885779. DOI: 10.1007/s12551-024-01267-6.

A Machine Learning Approach to Gene Expression in Hypertrophic Cardiomyopathy.

Pavic J, Zivanovic M, Tanaskovic I, Pavic O, Stankovic V, Virijevic K Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459004 PMC: 11510441. DOI: 10.3390/ph17101364.

Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy.

Jager J, Ribeiro M, Furtado M, Carvalho T, Syrris P, Lopes L Stem Cell Res. 2024; 81:103582.

PMID: 39447317 PMC: 11649531. DOI: 10.1016/j.scr.2024.103582.

CRISPR/Cas9 gene editing in induced pluripotent stem cells to investigate the feline hypertrophic cardiomyopathy causing MYBPC3/R820W mutation.

Dutton L, Dudhia J, Guest D, Connolly D PLoS One. 2024; 19(10):e0311761.

PMID: 39388496 PMC: 11466433. DOI: 10.1371/journal.pone.0311761.

Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.

Mori H, Xu D, Shimoda Y, Yuan Z, Murakata Y, Xi B Sci Rep. 2024; 14(1):15422.

PMID: 38965264 PMC: 11224225. DOI: 10.1038/s41598-024-62530-0.

References

Correia C, Koshkin A, Duarte P, Hu D, Teixeira A, Domian I . Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Sci Rep. 2017; 7(1):8590. PMC: 5561128. DOI: 10.1038/s41598-017-08713-4. View

Ho C, Day S, Colan S, Russell M, Towbin J, Sherrid M . The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. JAMA Cardiol. 2017; 2(4):419-428. PMC: 5541992. DOI: 10.1001/jamacardio.2016.5670. View

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

Li W, Ding S . Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci. 2009; 31(1):36-45. DOI: 10.1016/j.tips.2009.10.002. View

Gherghiceanu M, Barad L, Novak A, Reiter I, Itskovitz-Eldor J, Binah O . Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure. J Cell Mol Med. 2011; 15(11):2539-51. PMC: 3822963. DOI: 10.1111/j.1582-4934.2011.01417.x. View

Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C . Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003; 107(17):2227-32. DOI: 10.1161/01.CIR.0000066323.15244.54. View

Yang K, Breitbart A, de Lange W, Hofsteen P, Futakuchi-Tsuchida A, Xu J . Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells. JACC Basic Transl Sci. 2019; 3(6):728-740. PMC: 6314962. DOI: 10.1016/j.jacbts.2018.08.008. View

Yang L, Soonpaa M, Adler E, Roepke T, Kattman S, Kennedy M . Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194):524-8. DOI: 10.1038/nature06894. View

Lahmers S, Wu Y, Call D, Labeit S, Granzier H . Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res. 2004; 94(4):505-13. DOI: 10.1161/01.RES.0000115522.52554.86. View

10.

Erdmann J, Daehmlow S, Wischke S, Senyuva M, Werner U, Raible J . Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet. 2003; 64(4):339-49. DOI: 10.1034/j.1399-0004.2003.00151.x. View

11.

Ohi Y, Qin H, Hong C, Blouin L, Polo J, Guo T . Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol. 2011; 13(5):541-9. PMC: 3987913. DOI: 10.1038/ncb2239. View

12.

Seeger T, Shrestha R, Lam C, Chen C, McKeithan W, Lau E . A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay. Circulation. 2018; 139(6):799-811. PMC: 6443405. DOI: 10.1161/CIRCULATIONAHA.118.034624. View

13.

Abilez O, Tzatzalos E, Yang H, Zhao M, Jung G, Zollner A . Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. Stem Cells. 2017; 36(2):265-277. PMC: 5785460. DOI: 10.1002/stem.2732. View

14.

Wang J, Li W, Han Y, Chen Y . Different Clinical Presentation and Tissue Characterization in a Monozygotic Twin Pair with MYH7 Mutation-Related Hypertrophic Cardiomyopathy. Int Heart J. 2019; 60(2):477-481. DOI: 10.1536/ihj.18-167. View

15.

Jia W, Lu J, Zhang L, Cao H, Qi Y, Zhu H . An induced pluripotent stem cell line (EHTJUi003-A) generated from a neonate with c.1377delC mutation in the gene MYBPC3 causing hypertrophic cardiomyopathy. Stem Cell Res. 2021; 53:102328. DOI: 10.1016/j.scr.2021.102328. View

16.

Chung S, Dzeja P, Faustino R, Perez-Terzic C, Behfar A, Terzic A . Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med. 2007; 4 Suppl 1:S60-7. PMC: 3232050. DOI: 10.1038/ncpcardio0766. View

17.

Carrier L, Knoll R, Vignier N, Keller D, Bausero P, Prudhon B . Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res. 2004; 63(2):293-304. DOI: 10.1016/j.cardiores.2004.04.009. View

18.

Mearini G, Stimpel D, Kramer E, Geertz B, Braren I, Gedicke-Hornung C . Repair of Mybpc3 mRNA by 5'-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy. Mol Ther Nucleic Acids. 2013; 2:e102. PMC: 3731888. DOI: 10.1038/mtna.2013.31. View

19.

Chaudhari U, Nemade H, Wagh V, Gaspar J, Ellis J, Srinivasan S . Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Arch Toxicol. 2015; 90(11):2763-2777. PMC: 5065579. DOI: 10.1007/s00204-015-1623-5. View

20.

Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A . An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2012; 31(3):458-66. DOI: 10.1002/stem.1293. View